System Transmission

Top Signal

100#1 JOB

Activity

2184Ripe

+961 today

System

Live1m

Terminal Asset View

stockNASDAQ

SUPN

$49.91-1.09%

Supernus Pharmaceuticals Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

11Overripe

Live Analysis Active

Company Mission

Supernus Pharmaceuticals creates and sells prescription medications for brain-related conditions including attention deficit hyperactivity disorder (ADHD) and epilepsy. Doctors prescribe these medicines to patients who need treatment for these neurological disorders. The company makes money by selling these drugs to pharmacies, hospitals, and healthcare systems that then provide them to patients.

SUP

Industry Context

Supernus operates in the pharmaceutical industry, specifically focusing on neurological and psychiatric disorders. This sector experiences significant volatility around regulatory decisions and clinical trial results, with companies often seeing large price movements based on drug approval news or research developments.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

41Matrix

Market Momentum

39.9— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-1.09%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing SUPN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 01:54 PM UTC

As-of 03-15-2026 13:39 UTC

Develops prescription drugs for brain disorders and makes money by selling these medicines to pharmacies and hospitals.

Weekly price swings are getting smaller near recent lows, suggesting the stock is coiling tighter before a potential larger move.

Biotech sector volatility often increases during FDA decision periods, which could impact this company as it develops new treatments.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...